Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10942010 | 0.94 | LTA4H (0.46) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL11776519 | 0.85 | HRH1 (0.37) | LTA4HTSHRHTR1ASLC6A2SLC6A4 | |
| SCHEMBL1134992 | 0.82 | KDM1A (0.36) | KDM1A | |
| Phenol SCHEMBL9511612 | 0.82 | CA12 (0.44) | LTA4HTSHRNR1H2BAXTDP1 | |
| SCHEMBL14918384 | 0.80 | — | — | |
| SCHEMBL10876875 | 0.79 | KDM1A (0.34) | KDM1A | |
| SCHEMBL10876868 | 0.79 | KDM1A (0.34) | KDM1A | |
| SCHEMBL10876862 | 0.79 | KDM1A (0.34) | KDM1A | |
| SCHEMBL677021 | 0.79 | — | — | |
| SCHEMBL9049936 | 0.78 | PARP15 (0.47) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559656-A1 | PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1993-09-15 | — | — | EP | claimed |
| WO-1992009592-A1 | PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-06-11 | — | — | WO | claimed |
| US-20230090784-A1 | Photoredox Catalysts And Methods Of Using Such Catalysts | UNIV COLORADO STATE RES FOUND (US) | 2023-03-23 | — | — | US | disclosed |
| CN-115485067-A | Benzoperylene imide photoredox catalysts and methods of using such catalysts | 科罗拉多州立大学研究基金会 | 2022-12-16 | — | — | CN | disclosed |
| EP-4087679-A2 | BENZOPERYLENE IMIDE PHOTOREDOX CATALYSTS AND METHODS OF USING SUCH CATALYSTS | Colorado State University Research Foundation (US) | 2022-11-16 | — | — | EP | disclosed |
| WO-2021142444-A2 | PHOTOREDOX CATALYSTS AND METHODS OF USING SUCH CATALYSTS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-07-15 | — | — | WO | disclosed |
| US-10766851-B1 | Method to convert lignin 4-O-5 diaryl ethers and their model compounds into organic chemicals | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY (CA) | 2020-09-08 | — | — | US | disclosed |
| US-8551686-B2 | Antireflective composition for photoresists | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2013-10-08 | — | — | US | disclosed |
| US-5466838-A | Catalytic reaction of olefin with oxygen in the presence of aldehyde | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0540009-B1 | Process for producing epoxides | SUMITOMO CHEMICAL CO (JP) | 1995-08-30 | — | — | EP | disclosed |
| US-5367087-A | Process for producing epoxide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-11-22 | — | — | US | disclosed |
| EP-0540009-A1 | Process for producing epoxides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-05-05 | — | — | EP | disclosed |
| EP-0494140-A4 | DIBENZOFURANCARBOXAMIDES | — | 1992-09-02 | — | — | EP | disclosed |
| EP-0494140-A1 | DIBENZOFURANCARBOXAMIDES | RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1992009592-A1 | PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009284-A1 | 2,6-METHANO-2H-1-BENZOXOCINCARBOXAMIDES AS 5-HT3-ANTAGONISTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-4959485-A | 5-HT3 ANTAGONISTS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-09-25 | — | — | US | disclosed |
| WO-1989010364-A1 | DIBENZOFURANCARBOXAMIDES | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-11-02 | — | — | WO | disclosed |
| EP-0339950-A2 | Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1989-11-02 | — | — | EP | disclosed |
| US-4863921-A | Dibenzofurancarboxamides and their pharmaceutical compositions and methods | RORER PHARMACEUTICAL CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10766851-B1 | Method to convert lignin 4-O-5 diaryl ethers and their model compounds into organic chemicals | PPOX, DAO, PAH | LTA4H 738/4885TSHR 4656/4885NR1H2 1666/4885 |
| US-20230090784-A1 | Photoredox Catalysts And Methods Of Using Such Catalysts | PPOX, PAH, AHR | LTA4H 1501/4885TSHR 4697/4885NR1H2 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.